Tag:
Glybera
Latest Headlines
Latest Headlines
AMT's Glybera, delivered through virus, faces Euro reg delay
European regulators have slammed on the breaks and delayed an approval decision for Amsterdam Molecular Therapeutics ' Glybera, a gene therapy delivered by an altered virus for patients with a rare
Forbion raises $240M investment fund
European investment firm Forbion Capital Partners has announced the closing of a €190 million ($240m) life sciences investment fund. The VC--which has offices in the Netherlands and
